Investments
29Portfolio Exits
1Funds
2About Emergent Growth Fund
The Emergent Growth Funds are member-managed angel funds that focus on early stage companies. The members of the Emergent Growth funds are successful business people and investors.Although Emergent does not invest solely in companies or technologies that originate from the University of Florida or the surrounding geographic area, it is most attentive to those that do.The size of an investment made by Emergent can range from a low of $100,000, to more than $500,000 with add-on investments from our individual members. An average investment is likely in the range of $200,000 to $500,000. By investing side-by-side with one or more partner angel funds, Emergent Growth Fund can invest up to $2 million in an opportunity.
Emergent Growth Fund Headquarter Location
101 SE 2nd Place Suite 201C
Gainesville, Florida, 32601,
United States
(352) 335-3021
Emergent Growth Fund Investments
29 Investments
Emergent Growth Fund has made 29 investments. Their latest investment was in Arbovax as part of their Series C on October 10, 2011.
Emergent Growth Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/14/2011 | Series C | Arbovax | $1.73M | No | ||
10/12/2011 | Debt | Bacch Labs | $0.74M | No | ||
2/18/2011 | Series A | Bacch Labs | $1.56M | No | ||
12/8/2010 | Series B | |||||
7/14/2010 | Angel - III |
Date | 10/14/2011 | 10/12/2011 | 2/18/2011 | 12/8/2010 | 7/14/2010 |
|---|---|---|---|---|---|
Round | Series C | Debt | Series A | Series B | Angel - III |
Company | Arbovax | Bacch Labs | Bacch Labs | ||
Amount | $1.73M | $0.74M | $1.56M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources |
Emergent Growth Fund Portfolio Exits
1 Portfolio Exit
Emergent Growth Fund has 1 portfolio exit. Their latest portfolio exit was Clinipace on April 28, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/28/2021 | Merger | 4 |
Date | 4/28/2021 |
|---|---|
Exit | Merger |
Companies | |
Valuation | |
Acquirer | |
Sources | 4 |
Emergent Growth Fund Fund History
2 Fund Histories
Emergent Growth Fund has 2 funds, including EGFII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
7/10/2008 | EGFII | Early-Stage Venture Capital | Closed | $3M | 1 |
12/31/2003 | EGFI |
Closing Date | 7/10/2008 | 12/31/2003 |
|---|---|---|
Fund | EGFII | EGFI |
Fund Type | Early-Stage Venture Capital | |
Status | Closed | |
Amount | $3M | |
Sources | 1 |
Emergent Growth Fund Team
2 Team Members
Emergent Growth Fund has 2 team members, including current Founder, Russ Donda.
Name | Work History | Title | Status |
|---|---|---|---|
Russ Donda | BioEnterprise, HyGreen, Synogen Development Group, ViewRay, and RTI Surgical | Founder | Current |
Eric Buffkin Jr. | Founder | Current |
Name | Russ Donda | Eric Buffkin Jr. |
|---|---|---|
Work History | BioEnterprise, HyGreen, Synogen Development Group, ViewRay, and RTI Surgical | |
Title | Founder | Founder |
Status | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.